Indian firm seeks EUA in PH for its Covid-19 vaccine Covaxin
FILE PHOTO: A healthcare worker fills a syringe with a dose of Bharat Biotech’s Covid-19 vaccine called Covaxin, during the coronavirus disease vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
MANILA, Philippines — India-based firm Bharat Biotech has applied for emergency use authorization (EUA) for its Covid-19 vaccine Covaxin, the Food and Drug Administration (FDA) said Thursday.
“They submitted an application this morning and pre-evaluation is going on,” FDA Director-General Eric Domingo told INQUIRER.net in a text message.
Securing an EUA will allow a new vaccine to be administered in the country.
Other companies seeking EUA approval before the Philippine regulators are British firm AstraZeneca, Russian company Gamaleya Research Institute and Chinese drug maker Sinovac Biotech.
So far, only US pharmaceutical giant Pfizer has secured the FDA clearance for its vaccine’s use in the Philippines.
JPV
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.
